{
    "clinical_study": {
        "@rank": "166441", 
        "arm_group": {
            "arm_group_label": "Fentanyl transdermal patch", 
            "arm_group_type": "Experimental", 
            "description": "Fentanyl transdermal patches releasing 12.5 microgram of fentanyl will be applied for 3 days. The patches will be replaced every 3 days (Day 3, 7 and 10)."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the efficacy and safety of fentanyl  among Filipino\n      participants with osteoarthritis (disorder which is seen mostly in older persons in which\n      the joints become painful and stiff) and chronic (lasting a long time) low back pain."
        }, 
        "brief_title": "An Efficacy and Safety Study of Fentanyl Transdermal Patch in Filipino Participants With Osteoarthritis and Chronic Low Back Pain", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": {
                        "@group_id": "B1", 
                        "description": "Fentanyl transdermal patches releasing 12.5 mcg of fentanyl were applied for 3 days. The patches were replaced every 3 days (Day 3, 7 and 10) with an increase in dose by 12.5 mcg to a maximum of 50 mcg.", 
                        "title": "Fentanyl"
                    }
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@value": "237"
                                        }
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@spread": "11.137", 
                                            "@value": "48.202"
                                        }
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Age", 
                            "units": "Years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "174"
                                            }
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "63"
                                            }
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "Participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "46"
                                            }
                                        }, 
                                        "sub_title": "Not evaluated"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "21"
                                            }
                                        }, 
                                        "sub_title": "No change"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "38"
                                            }
                                        }, 
                                        "sub_title": "Minimally improved"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "93"
                                            }
                                        }, 
                                        "sub_title": "Much improved"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "5"
                                            }
                                        }, 
                                        "sub_title": "Very Much improved"
                                    }
                                ]
                            }, 
                            "description": "CGI-I is a 7-point scale that requires the clinician to assess how much the participant's illness has improved or worsened relative to a baseline state at the beginning of the intervention and rated as: 1=very much improved; 2=much improved; 3=minimally improved; 4=no change; 5=minimally worse; 6=much worse; 7=very much worse. Here, 'N' signifies the participants analyzed for this study specific Baseline characteristic and is Intent-to-treat population defined as all the participants who received at least 1 dose of study medication and had at least 1 follow-up visit with assessment=203.", 
                            "param": "Number", 
                            "title": "Number of Participants With Clinical Global Impression-Improvement (CGI-I) Score: Clinician", 
                            "units": "Participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "46"
                                            }
                                        }, 
                                        "sub_title": "Not evaluated"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "21"
                                            }
                                        }, 
                                        "sub_title": "No change"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "40"
                                            }
                                        }, 
                                        "sub_title": "Minimally improved"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "88"
                                            }
                                        }, 
                                        "sub_title": "Much improved"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "8"
                                            }
                                        }, 
                                        "sub_title": "Very Much improved"
                                    }
                                ]
                            }, 
                            "description": "CGI-I is a 7-point scale that requires the participant to assess how much the participant's illness has improved or worsened relative to a baseline state at the beginning of the intervention and rated as: 1=very much improved; 2=much improved; 3=minimally improved; 4=no change; 5=minimally worse; 6=much worse; 7=very much worse. Number of participants analysed for this study specific Baseline characteristic=203.", 
                            "param": "Number", 
                            "title": "Number of Participants With Clinical Global Impression-Improvement (CGI-I) Score: Participant", 
                            "units": "Participant"
                        }
                    ]
                }
            }, 
            "certain_agreements": {
                "pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.", 
                "restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed."
            }, 
            "outcome_list": {
                "outcome": [
                    {
                        "description": "BPI is an 11-item self-report questionnaire that is designed to assess the severity and impact of pain on daily functions. BPI- severity consists of 4 questions (items) that assess pain intensity (worst, least, average, right now). Each question (item) is answered on a scale ranging from 0 to 10; \u20180=No pain and 10=Pain as bad as you can imagine\u2019. Measure can be scored by item, with lower scores being indicative of less pain or pain interference. Change: Score at Day 30 minus score at Baseline.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Fentanyl transdermal patches releasing 12.5 mcg of fentanyl were applied for 3 days. The patches were replaced every 3 days (Day 3, 7 and 10) with an increase in dose by 12.5 mcg to a maximum of 50 mcg.", 
                                "title": "Fentanyl"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "203"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "1.922", 
                                                        "@value": "7.20"
                                                    }
                                                }, 
                                                "sub_title": "Baseline: Worst"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "1.904", 
                                                        "@value": "3.83"
                                                    }
                                                }, 
                                                "sub_title": "Baseline: Least"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "1.682", 
                                                        "@value": "5.59"
                                                    }
                                                }, 
                                                "sub_title": "Baseline: Average"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "2.121", 
                                                        "@value": "5.49"
                                                    }
                                                }, 
                                                "sub_title": "Baseline: Right now"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "2.661", 
                                                        "@value": "-5.000"
                                                    }
                                                }, 
                                                "sub_title": "Change at Day 30: Worst"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "2.124", 
                                                        "@value": "-3.049"
                                                    }
                                                }, 
                                                "sub_title": "Change at Day 30: Least"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "2.096", 
                                                        "@value": "-4.246"
                                                    }
                                                }, 
                                                "sub_title": "Change at Day 30: Average"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "2.464", 
                                                        "@value": "-4.404"
                                                    }
                                                }, 
                                                "sub_title": "Change at Day 30: Right now"
                                            }
                                        ]
                                    }, 
                                    "description": "BPI is an 11-item self-report questionnaire that is designed to assess the severity and impact of pain on daily functions. BPI- severity consists of 4 questions (items) that assess pain intensity (worst, least, average, right now). Each question (item) is answered on a scale ranging from 0 to 10; \u20180=No pain and 10=Pain as bad as you can imagine\u2019. Measure can be scored by item, with lower scores being indicative of less pain or pain interference. Change: Score at Day 30 minus score at Baseline.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Change From Baseline in Brief Pain Inventory (BPI) Severity Score at Day 30", 
                                    "units": "Units on a scale"
                                }
                            ]
                        }, 
                        "population": "The intent-to-treat (ITT) population was defined as all the participants who received at least 1 dose of study medication and had at least 1 follow-up visit with assessment.", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline and Day 30", 
                        "title": "Change From Baseline in Brief Pain Inventory (BPI) Severity Score at Day 30", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "BPI is an 11-item self-report questionnaire that is designed to assess the severity and impact of pain on daily functions. BPI-interference consists of 7 questions (items) that assess impact of pain on daily functions (general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life). Each question (item) is answered on a scale ranging from 0 to 10; \u20180=No pain and 10=Pain as bad as you can imagine\u2019. Measure can be scored by item, with lower scores being indicative of less pain or pain interference. Change: Score at Day 30 minus score at Baseline.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Fentanyl transdermal patches releasing 12.5 mcg of fentanyl were applied for 3 days. The patches were replaced every 3 days (Day 3, 7 and 10) with an increase in dose by 12.5 mcg to a maximum of 50 mcg.", 
                                "title": "Fentanyl"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "203"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "2.020", 
                                                        "@value": "5.73"
                                                    }
                                                }, 
                                                "sub_title": "Baseline: General activity"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "2.288", 
                                                        "@value": "4.94"
                                                    }
                                                }, 
                                                "sub_title": "Baseline: Mood"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "2.417", 
                                                        "@value": "5.25"
                                                    }
                                                }, 
                                                "sub_title": "Baseline: Walking ability"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "2.242", 
                                                        "@value": "5.34"
                                                    }
                                                }, 
                                                "sub_title": "Baseline: Normal work"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "2.345", 
                                                        "@value": "4.33"
                                                    }
                                                }, 
                                                "sub_title": "Baseline: Relationship w/others"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "2.430", 
                                                        "@value": "5.05"
                                                    }
                                                }, 
                                                "sub_title": "Baseline: Sleep"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "2.513", 
                                                        "@value": "4.71"
                                                    }
                                                }, 
                                                "sub_title": "Baseline: Enjoyment of life"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "2.470", 
                                                        "@value": "-4.502"
                                                    }
                                                }, 
                                                "sub_title": "Change at Day 30: General activity"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "2.487", 
                                                        "@value": "-4.118"
                                                    }
                                                }, 
                                                "sub_title": "Change at Day 30: Mood"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "2.618", 
                                                        "@value": "-4.182"
                                                    }
                                                }, 
                                                "sub_title": "Change at Day 30: Walking ability"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "2.504", 
                                                        "@value": "-4.251"
                                                    }
                                                }, 
                                                "sub_title": "Change at Day 30: Normal work"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "2.486", 
                                                        "@value": "-3.700"
                                                    }
                                                }, 
                                                "sub_title": "Change at Day 30: Relationship w/others"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "2.639", 
                                                        "@value": "-4.355"
                                                    }
                                                }, 
                                                "sub_title": "Change at Day 30: Sleep"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "2.611", 
                                                        "@value": "-3.966"
                                                    }
                                                }, 
                                                "sub_title": "Change at Day 30: Enjoyment of life"
                                            }
                                        ]
                                    }, 
                                    "description": "BPI is an 11-item self-report questionnaire that is designed to assess the severity and impact of pain on daily functions. BPI-interference consists of 7 questions (items) that assess impact of pain on daily functions (general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life). Each question (item) is answered on a scale ranging from 0 to 10; \u20180=No pain and 10=Pain as bad as you can imagine\u2019. Measure can be scored by item, with lower scores being indicative of less pain or pain interference. Change: Score at Day 30 minus score at Baseline.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Change From Baseline in Brief Pain Inventory (BPI) Interference Score at Day 30", 
                                    "units": "Units on a scale"
                                }
                            ]
                        }, 
                        "population": "The ITT population was defined as all the participants who received at least 1 dose of study medication and had at least 1 follow-up visit with assessment.", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline and Day 30", 
                        "title": "Change From Baseline in Brief Pain Inventory (BPI) Interference Score at Day 30", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Rescue medications are periodic supplemental doses of analgesic which might be required to control pain. Tramadol 50mg tablet at a maximum of 6 tablets per day was used as standard rescue medication.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Fentanyl transdermal patches releasing 12.5 mcg of fentanyl were applied for 3 days. The patches were replaced every 3 days (Day 3, 7 and 10) with an increase in dose by 12.5 mcg to a maximum of 50 mcg.", 
                                "title": "Fentanyl"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "237"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "41"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Rescue medications are periodic supplemental doses of analgesic which might be required to control pain. Tramadol 50mg tablet at a maximum of 6 tablets per day was used as standard rescue medication.", 
                                    "param": "Number", 
                                    "title": "Number of Participants Requiring Rescue Medication", 
                                    "units": "Participants"
                                }
                            ]
                        }, 
                        "population": "All participants suffering from osteoarthritis (disorder, which is seen mostly in older persons, in which the joints become painful and stuff) and chronic (lasting a long time) low back pain and who took at least 1 dose of study medication and had at least 1 follow-up visit during the study.", 
                        "safety_issue": "No", 
                        "time_frame": "Day 30", 
                        "title": "Number of Participants Requiring Rescue Medication", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "CGI-I is a 7-point scale that requires the clinician to assess how much the participant's illness has improved or worsened relative to a baseline state at the beginning of the intervention and rated as: 1=very much improved; 2=much improved; 3=minimally improved; 4=no change; 5=minimally worse; 6=much worse; 7=very much worse.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Fentanyl transdermal patches releasing 12.5 mcg of fentanyl were applied for 3 days. The patches were replaced every 3 days (Day 3, 7 and 10) with an increase in dose by 12.5 mcg to a maximum of 50 mcg.", 
                                "title": "Fentanyl"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "203"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@value": "1"
                                                    }
                                                }, 
                                                "sub_title": "Very much worse"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@value": "5"
                                                    }
                                                }, 
                                                "sub_title": "No change"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@value": "16"
                                                    }
                                                }, 
                                                "sub_title": "Minimally improved"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@value": "30"
                                                    }
                                                }, 
                                                "sub_title": "Much improved"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@value": "151"
                                                    }
                                                }, 
                                                "sub_title": "Very Much improved"
                                            }
                                        ]
                                    }, 
                                    "description": "CGI-I is a 7-point scale that requires the clinician to assess how much the participant's illness has improved or worsened relative to a baseline state at the beginning of the intervention and rated as: 1=very much improved; 2=much improved; 3=minimally improved; 4=no change; 5=minimally worse; 6=much worse; 7=very much worse.", 
                                    "param": "Number", 
                                    "title": "Number of Participants With Clinical Global Impression-Improvement (CGI-I) Score: Clinician", 
                                    "units": "Participants"
                                }
                            ]
                        }, 
                        "population": "The ITT population was defined as all the participants who received at least 1 dose of study medication and had at least 1 follow-up visit with assessment.", 
                        "safety_issue": "No", 
                        "time_frame": "Day 30", 
                        "title": "Number of Participants With Clinical Global Impression-Improvement (CGI-I) Score: Clinician", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "CGI-I is a 7-point scale that requires the Participant to assess how much the participant's illness has improved or worsened relative to a baseline state at the beginning of the intervention and rated as: 1=very much improved; 2=much improved; 3=minimally improved; 4=no change; 5=minimally worse; 6=much worse; 7=very much worse.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Fentanyl transdermal patches releasing 12.5 mcg of fentanyl were applied for 3 days. The patches were replaced every 3 days (Day 3, 7 and 10) with an increase in dose by 12.5 mcg to a maximum of 50 mcg.", 
                                "title": "Fentanyl"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "203"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@value": "1"
                                                    }
                                                }, 
                                                "sub_title": "Very much worse"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@value": "1"
                                                    }
                                                }, 
                                                "sub_title": "Minimally worse"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@value": "5"
                                                    }
                                                }, 
                                                "sub_title": "No change"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@value": "14"
                                                    }
                                                }, 
                                                "sub_title": "Minimally improved"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@value": "33"
                                                    }
                                                }, 
                                                "sub_title": "Much improved"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@value": "149"
                                                    }
                                                }, 
                                                "sub_title": "Very Much improved"
                                            }
                                        ]
                                    }, 
                                    "description": "CGI-I is a 7-point scale that requires the Participant to assess how much the participant's illness has improved or worsened relative to a baseline state at the beginning of the intervention and rated as: 1=very much improved; 2=much improved; 3=minimally improved; 4=no change; 5=minimally worse; 6=much worse; 7=very much worse.", 
                                    "param": "Number", 
                                    "title": "Number of Participants With Clinical Global Impression-Improvement (CGI-I) Score: Participant", 
                                    "units": "Participants"
                                }
                            ]
                        }, 
                        "population": "The ITT population was defined as all the participants who received at least 1 dose of study medication and had at least 1 follow-up visit with assessment.", 
                        "safety_issue": "No", 
                        "time_frame": "Day 30", 
                        "title": "Number of Participants With Clinical Global Impression-Improvement (CGI-I) Score: Participant", 
                        "type": "Primary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": {
                        "@group_id": "P1", 
                        "description": "Fentanyl transdermal (through the skin) patches releasing 12.5 microgram (mcg) of fentanyl were applied for 3 days. The patches were replaced every 3 days (Day 3, 7 and 10) with an increase in dose by 12.5 mcg to a maximum of 50 mcg.", 
                        "title": "Fentanyl"
                    }
                }, 
                "period_list": {
                    "period": {
                        "drop_withdraw_reason_list": {
                            "drop_withdraw_reason": [
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "27", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "Adverse Event"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "20", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "Lost to Follow-up"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "6", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "Withdrawal of consent"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "1", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "Diagnosed with metastasis"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "1", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "No pain"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "1", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "Death"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "3", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "Withdrew consent & had adverse events"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "1", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "Physician Decision"
                                }
                            ]
                        }, 
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "237", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "177", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "60", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }
            }, 
            "point_of_contact": {
                "name_or_title": "Medical Affairs Manager", 
                "organization": "Janssen Philippines", 
                "phone": "+632-8247901"
            }, 
            "reported_events": {
                "group_list": {
                    "group": {
                        "@group_id": "E1", 
                        "description": "Fentanyl transdermal patches releasing 12.5 mcg of fentanyl were applied for 3 days. The patches were replaced every 3 days (Day 3, 7 and 10) with an increase in dose by 12.5 mcg to a maximum of 50 mcg.", 
                        "title": "Fentanyl"
                    }
                }, 
                "other_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "156", 
                                            "@subjects_at_risk": "237"
                                        }, 
                                        "sub_title": "Total, other adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "128", 
                                                "@subjects_at_risk": "237"
                                            }, 
                                            "sub_title": "Dizziness"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "92", 
                                                "@subjects_at_risk": "237"
                                            }, 
                                            "sub_title": "Nausea"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "61", 
                                                "@subjects_at_risk": "237"
                                            }, 
                                            "sub_title": "Vomiting"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "39", 
                                                "@subjects_at_risk": "237"
                                            }, 
                                            "sub_title": "Somnolence"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "13", 
                                                "@subjects_at_risk": "237"
                                            }, 
                                            "sub_title": "Pruritus"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "5", 
                                                "@subjects_at_risk": "237"
                                            }, 
                                            "sub_title": "Insomnia"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "4", 
                                                "@subjects_at_risk": "237"
                                            }, 
                                            "sub_title": "Headache"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "3", 
                                                "@subjects_at_risk": "237"
                                            }, 
                                            "sub_title": "Palpitation"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "3", 
                                                "@subjects_at_risk": "237"
                                            }, 
                                            "sub_title": "Rashes"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "3", 
                                                "@subjects_at_risk": "237"
                                            }, 
                                            "sub_title": "Weakness"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "237"
                                            }, 
                                            "sub_title": "Chest pain"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "237"
                                            }, 
                                            "sub_title": "Cold clammy perspiration"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "237"
                                            }, 
                                            "sub_title": "Flushing"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "237"
                                            }, 
                                            "sub_title": "Muscle trembling"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "237"
                                            }, 
                                            "sub_title": "Arm heaviness"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "237"
                                            }, 
                                            "sub_title": "Blurring of vision"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "237"
                                            }, 
                                            "sub_title": "Chills"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "3", 
                                                "@subjects_at_risk": "237"
                                            }, 
                                            "sub_title": "Constipation"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "237"
                                            }, 
                                            "sub_title": "Dryness of mouth"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "237"
                                            }, 
                                            "sub_title": "Dyspepsia"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "237"
                                            }, 
                                            "sub_title": "Hematoma"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "237"
                                            }, 
                                            "sub_title": "Hypertension"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "237"
                                            }, 
                                            "sub_title": "Swelling of both ankles"
                                        }
                                    ]
                                }, 
                                "title": "General disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Non-systematic Assessment", 
                    "frequency_threshold": "0"
                }, 
                "serious_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "5", 
                                            "@subjects_at_risk": "237"
                                        }, 
                                        "sub_title": "Total, serious adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "237"
                                            }, 
                                            "sub_title": "Bradycardia"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "237"
                                            }, 
                                            "sub_title": "Palpitations"
                                        }
                                    ]
                                }, 
                                "title": "Cardiac disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "237"
                                            }, 
                                            "sub_title": "Nausea"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "237"
                                            }, 
                                            "sub_title": "Vomiting"
                                        }
                                    ]
                                }, 
                                "title": "Gastrointestinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "237"
                                        }, 
                                        "sub_title": "Musculoskeletal pain"
                                    }
                                }, 
                                "title": "Musculoskeletal and connective tissue disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "237"
                                            }, 
                                            "sub_title": "Hypoaesthesia"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "237"
                                            }, 
                                            "sub_title": "Dizziness"
                                        }
                                    ]
                                }, 
                                "title": "Nervous system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "237"
                                        }, 
                                        "sub_title": "Erythema nodosum"
                                    }
                                }, 
                                "title": "Skin and subcutaneous tissue disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "1"
                                            }, 
                                            "sub_title": "Aneurysm ruptured"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "237"
                                            }, 
                                            "sub_title": "Hypertension"
                                        }
                                    ]
                                }, 
                                "title": "Vascular disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Non-systematic Assessment"
                }, 
                "time_frame": "Baseline up to Day 30"
            }
        }, 
        "completion_date": {
            "#text": "September 2009", 
            "@type": "Actual"
        }, 
        "condition": [
            "Osteoarthritis", 
            "Low Back Pain"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Back Pain", 
                "Low Back Pain", 
                "Osteoarthritis"
            ]
        }, 
        "detailed_description": {
            "textblock": "This is an open-label (a medical research study in which participants and researchers are\n      told which treatments the participants are receiving, \"unblinded\") single-arm and\n      prospective study (study following participants forward in time) of fentanyl in participants\n      with osteoarthritis and Chronic low back pain with moderate (medium level of seriousness)\n      and severe (very serious, life threatening) pain levels. Participants will be treated with\n      fentanyl transdermal patch (patch containing a drug that is put on the skin so the drug will\n      enter the body through the skin) starting with 12.5 microgram (mcg) dose of fentanyl. The\n      dose will be increased on Day 3, if needed, by 12.5 mcg. Dose adjustments will be done every\n      3 days. Maximum of 50 mcg dose of fentanyl will be allowed. Participants will be evaluated\n      for pain levels and quality of life using Brief pain inventory (BPI) score and Clinical\n      global impression-severity (CGI-S) score. Tramadol 50 milligram tablet at a maximum of 6\n      tablets per day will be used as supplemental doses of analgesic (drug used to control pain).\n      Participants' safety will be monitored through out the study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Participants diagnosed with osteoarthritis and chronic low back pain\n\n          -  3 months of persistent moderate to severe pain levels\n\n          -  More than 3 times a week frequency or daily moderate to severe pain\n\n          -  Moderate to severe pain at Baseline (at least a score of 4 in the 11-point numerical\n             pain scale) Exclusion Criteria\n\n          -  History of allergy to fentanyl transdermal patch or its components and  history of\n             illicit drug use for the past 3 months\n\n          -  Active skin disease preventing application of the transdermal system\n\n          -  Chronic pulmonary disease (lung disorder)\n\n          -  Participants susceptible to intracranial (inside the skull) effects of carbon dioxide\n             retention\n\n          -  Pregnant and breastfeeding mothers"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "237", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 19, 2013", 
        "firstreceived_results_date": "March 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01795898", 
            "org_study_id": "CR015268", 
            "secondary_id": "FENPAI4074"
        }, 
        "intervention": {
            "arm_group_label": "Fentanyl transdermal patch", 
            "description": "Fentanyl transdermal patches releasing 12.5 microgram of fentanyl will be applied for 3 days. The patches will be replaced every 3 days (Day 3, 7 and 10).", 
            "intervention_name": "Fentanyl", 
            "intervention_type": "Drug", 
            "other_name": "DUROGESIC-D-TRANS"
        }, 
        "intervention_browse": {
            "mesh_term": "Fentanyl"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Osteoarthritis", 
            "Low back pain", 
            "Fentanyl transdermal patch", 
            "Durogesic-D-Trans"
        ], 
        "lastchanged_date": "June 10, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Quezon City", 
                    "country": "Philippines"
                }
            }
        }, 
        "location_countries": {
            "country": "Philippines"
        }, 
        "number_of_arms": "1", 
        "official_title": "Efficacy, Safety and Quality of Life Outcome of Fentanyl Transdermal Patch (Durogesic-D-Trans) Among Filipino Patients With Osteoarthritis and Chronic Low Back Pain", 
        "overall_official": {
            "affiliation": "Janssen Pharmaceutica", 
            "last_name": "Janssen Pharmaceutica Clinical trial", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Philippines : Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "September 2009", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "BPI is an 11-item self-report questionnaire that is designed to assess the severity and impact of pain on daily functions. BPI- severity consists of 4 questions (items) that assess pain intensity (worst, least, average, right now). Each question (item) is answered on a scale ranging from 0 to 10; '0=No pain and 10=Pain as bad as you can imagine'. Measure can be scored by item, with lower scores being indicative of less pain or pain interference. Change: Score at Day 30 minus score at Baseline.", 
                "measure": "Change From Baseline in Brief Pain Inventory (BPI) Severity Score at Day 30", 
                "safety_issue": "No", 
                "time_frame": "Baseline and Day 30"
            }, 
            {
                "description": "BPI is an 11-item self-report questionnaire that is designed to assess the severity and impact of pain on daily functions. BPI-interference consists of 7 questions (items) that assess impact of pain on daily functions (general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life). Each question (item) is answered on a scale ranging from 0 to 10; '0=No pain and 10=Pain as bad as you can imagine'. Measure can be scored by item, with lower scores being indicative of less pain or pain interference. Change: Score at Day 30 minus score at Baseline.", 
                "measure": "Change From Baseline in Brief Pain Inventory (BPI) Interference Score at Day 30", 
                "safety_issue": "No", 
                "time_frame": "Baseline and Day 30"
            }, 
            {
                "description": "Rescue medications are periodic supplemental doses of analgesic which might be required to control pain. Tramadol 50mg tablet at a maximum of 6 tablets per day was used as standard rescue medication.", 
                "measure": "Number of Participants Requiring Rescue Medication", 
                "safety_issue": "No", 
                "time_frame": "Day 30"
            }, 
            {
                "description": "CGI-I is a 7-point scale that requires the clinician to assess how much the participant's illness has improved or worsened relative to a baseline state at the beginning of the intervention and rated as: 1=very much improved; 2=much improved; 3=minimally improved; 4=no change; 5=minimally worse; 6=much worse; 7=very much worse.", 
                "measure": "Number of Participants With Clinical Global Impression-Improvement (CGI-I) Score: Clinician", 
                "safety_issue": "No", 
                "time_frame": "Day 30"
            }, 
            {
                "description": "CGI-I is a 7-point scale that requires the Participant to assess how much the participant's illness has improved or worsened relative to a baseline state at the beginning of the intervention and rated as: 1=very much improved; 2=much improved; 3=minimally improved; 4=no change; 5=minimally worse; 6=much worse; 7=very much worse.", 
                "measure": "Number of Participants With Clinical Global Impression-Improvement (CGI-I) Score: Participant", 
                "safety_issue": "No", 
                "time_frame": "Day 30"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01795898"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Janssen Pharmaceutica", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Janssen Pharmaceutica", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2009", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}